297 The nucleotide analogue prodrug remdesivir reduces viral load and lung disease in a rhesus macaque model of SARS-CoV-2 infection.
https://www.nature.com/articles/s41586-020-2423-5
296 Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans
https://science.sciencemag.org/content/369/6508/1210
295 Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications.
https://science.sciencemag.org/content/369/6508/eabc8511
294 COVID-19 severity correlates with airway epithelium–immune cell interactions identified by single-cell analysis.
https://www.nature.com/articles/s41587-020-0602-4
293 The implications of silent transmission for the control of COVID-19 outbreaks.
https://www.pnas.org/content/117/30/17513
292 Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report.
https://www.nejm.org/doi/full/10.1056/NEJMoa2021436?query=featured_home
291 Single-dose baloxavir showed significant postexposure prophylactic efficacy in preventing influenza in household contacts of patients with influenza.
https://www.nejm.org/doi/full/10.1056/NEJMoa1915341?query=featured_home
290 Favorable Anakinra Responses in Severe Covid-19 Patients with Secondary Hemophagocytic Lymphohistiocytosis.
https://www.cell.com/cell-host-microbe/fulltext/S1931-3128(20)30289-4
289 Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD.
https://www.nejm.org/doi/full/10.1056/NEJMoa1916046?query=featured_home
288 Amoxicillin for 3 or 5 Days for Chest-Indrawing Pneumonia in Malawian Children.
https://www.nejm.org/doi/full/10.1056/NEJMoa1912400?query=featured_home
287 A mobile app, the COVID Symptom Study, offers data on risk factors, early symptoms, clinical outcomes, and geographical hotspots.
https://science.sciencemag.org/content/368/6497/1362
286 Coast-to-Coast Spread of SARS-CoV-2 during the Early Epidemic in the United States.
https://www.cell.com/cell/fulltext/S0092-8674(20)30484-0
285 Remdesivir for the Treatment of Covid-19 — Preliminary Report.
https://www.nejm.org/doi/full/10.1056/NEJMoa2007764?query=featured_home
284 Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.
https://onlinelibrary.wiley.com/doi/full/10.1111/jth.14817
283 Severe Covid-19.
https://www.nejm.org/doi/full/10.1056/NEJMcp2009575?query=featured_home
282 Feedback between the epidemic process, the behavioral response to it, and nationwide containment policies can restrain COVID-19.
https://science.sciencemag.org/content/368/6492/742
281 Spread and dynamics of the COVID-19 epidemic in Italy: Effects of emergency containment measures.
https://www.pnas.org/content/117/19/10484
280 Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial.
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31042-4/fulltext
279 Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19.
https://www.nejm.org/doi/full/10.1056/NEJMoa2012410?query=featured_home
278 Travel restrictions and the national emergency response delayed the growth and limited the size of the COVID-19 epidemic in China.
https://science.sciencemag.org/content/368/6491/638
|
